• Skip to main content

DistilINFO LifeSciences

Weekly round up from Life Sciences Industry.

  • Publications
    • Home
    • DistilINFO HealthPlan
    • DistilINFO HospitalIT
    • DistilINFO IT
    • DistilINFO Retail
    • DistilINFO POPHealth
    • DistilINFO Ageing
    • DistilINFO Life Sciences
    • DistilINFO GovHealth
    • DistilINFO EHS
    • DistilINFO HealthIndia
    • Subscribe
    • Submit Article
    • Advertise
    • Newsletters

Tilray, Inc. Completes Merger With Privateer Holdings, Inc.

Share:

December 16, 2019

Tilray, Inc. (“Tilray” or the “Company”) (Nasdaq:TLRY), a global pioneer in cannabis research, cultivation, production and distribution, today announced that the merger with Privateer Holdings, Inc. (“Privateer”), closed on December 12, 2019.

Mark Castaneda, Chief Financial Officer of Tilray, said: “We appreciate the long-term confidence that Privateer has in the Tilray business and we look forward to having their investors as part of our stockholder base. We believe this transaction will give Tilray greater control and operating flexibility, while allowing us to effectively manage our public float.”

Pursuant to the merger, all of Privateer’s capital stock outstanding immediately prior to the effective time of the merger (excluding certain shares) were cancelled and automatically converted solely into the right to receive the applicable portion of an aggregate shares of Tilray Class 2 common stock and shares of Tilray Class 1 common stock (inclusive of shares of Tilray Class 2 common stock held in escrow for contingent release to Privateer’s stockholders) issuable as consideration in merger. Tilray did not pay any cash consideration in connection with the merger.

As previously disclosed, each Privateer equity holder who received the shares of Tilray stock in the merger is subject to a lock-up allowing for the sale of such shares only under certain circumstances over a two-year period. During the first year following the closing of the merger, shares will be released only pursuant to certain offerings or sales arranged by and at the discretion of Tilray. At the end of the first year, to the extent not already released at Tilray’s discretion as a result of the aforementioned offerings or sales, 50 percent of the total shares subject to the lock-up will be released. Over the course of the second year following closing, the remaining shares will be subject to a staggered release in four equal quarterly increments.

Want to publish your own articles on DistilINFO Publications?

Send us an email, we will get in touch with you.

Source: Yahoo Finance

Coffee with DistilINFO's Morning Updates...

Sign up for DistilINFO e-Newsletters.

Just a little bit more about you...
PROCEED
Choose Lists
BACK

Related Stories

  • Top 12 takeaways from the 2018 JP Morgan Healthcare Conference — while the destination is uncertain, the direction is clearTop 12 takeaways from the 2018 JP Morgan Healthcare Conference — while the destination is uncertain, the direction is clear
  • VA Telehealth Expansion Lagged in Rural Areas During COVID-19VA Telehealth Expansion Lagged in Rural Areas During COVID-19
  • Digital Cardiac Care Startup Heartbeat Health Lands $8.2M in Series a FundingDigital Cardiac Care Startup Heartbeat Health Lands $8.2M in Series a Funding
  • Greenway Health Launches Customizable RCM SolutionGreenway Health Launches Customizable RCM Solution
  • Payment Integrity: Is AI The Real Answer to Reducing Overutilization?Payment Integrity: Is AI The Real Answer to Reducing Overutilization?
  • FDA Clears ICU Device That Predicts Respiratory Failure to Support COVID-19FDA Clears ICU Device That Predicts Respiratory Failure to Support COVID-19
  • HiberCell Announces Acquisition of Biothera Pharmaceuticals’ Imprime PGG ProgramHiberCell Announces Acquisition of Biothera Pharmaceuticals’ Imprime PGG Program
  • SVB Financial Group to Buy Venture Capital Firm Leerink, a Top 10 Underwriter for Biotech IPOsSVB Financial Group to Buy Venture Capital Firm Leerink, a Top 10 Underwriter for Biotech IPOs

Trending This Week

Sorry. No data so far.

About Us

DistilINFO is media company that publishes Industry news, views and Interviews. We distil the information for you – saving time and keeping you up to date on your interest areas.

More About Us

Follow Us


Useful Links

  • Subscribe
  • Contact
  • Advertise
  • Privacy Policy
  • Terms of Service
  • Feedback

All Publications

  • DistilINFO HealthPlan Advisory
  • DistilINFO HospitalIT Advisory
  • DistilINFO IT Advisory
  • DistilINFO Retail Advisory
  • DistilINFO POPHealth Advisory
  • DistilINFO Ageing Advisory
  • DistilINFO Life Sciences Advisory
  • DistilINFO GovHealth Advisory
  • DistilINFO EHS Advisory
  • DistilINFO HealthIndia Advisory

© DistilINFO Publications